Michael Zinda, EVP, Chief Science Officer at Repare Therapeutics Inc. (RPTX), sold 20,000 shares at $27.20 ($547K) on 2021-11-15, disclosed to the SEC on 2021-11-17.
Open-market sale of $547k RPTX by EVP, Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.20 | 16,100 | $438K | 80.1% |
| 2 | $27.87 | 3,900 | $109K | 19.9% |
| Total | $27.33 avg | 20,000 | $547K | 100% |
| Filing → |
| RPTX | SELL | 2024-03-27 | $6K | — | Filing → |
| RPTX | SELL | 2023-06-09 | $189K | — | Filing → |
| RPTX | SELL | 2023-06-07 | $14K | — | Filing → |